A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2009
11/05/2009	WO2009133940A1 Pharmaceutical agent for promoting the functional regeneration of damaged tissue
11/05/2009	WO2009133939A1 Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
11/05/2009	WO2009133863A1 Immunopotentiating agent comprising ep1 agonist
11/05/2009	WO2009133861A1 Cyclic amine compound
11/05/2009	WO2009133834A1 Keto-amide derivative having inhibitory activity on endothelial lipase
11/05/2009	WO2009133831A1 Phenylpropionic acid derivative and use thereof
11/05/2009	WO2009133687A1 Cyclopentylacrylic acid amide derivative
11/05/2009	WO2009133610A1 Skin patch instrument for treating pain
11/05/2009	WO2009133310A2 Combination of dronedarone with at least one diuretic, and therapeutic use thereof
11/05/2009	WO2009133137A2 Pegylated recombinant human growth hormone compounds
11/05/2009	WO2009114729A3 Compounds, compositions and methods for treating lysosomal storage diseases and disorders
11/05/2009	WO2009112653A3 Cosmetic and/or dermatological composition
11/05/2009	US20090275751 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
11/05/2009	US20090275664 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/05/2009	US20090275576 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
11/05/2009	US20090275572 Fab i inhibitors
11/05/2009	US20090275545 Medicinal targeted local lipolysis
11/05/2009	US20090275516 Compounds and method for modulating inflammatory reactions
11/05/2009	US20090275041 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
11/05/2009	US20090274784 Aqueous extract of stems or leaves or stems and leaves of one or more Cissus quandragularis plants to promote weight loss; combined with chitosan and amylase inhibitor
11/05/2009	US20090274777 Dietetic composition
11/05/2009	US20090274740 Drug-loaded medical devices and methods for manufacturing drug-loaded medical devices
11/05/2009	US20090274729 Media for clostridium bacterium and processes for obtaining a clostridial toxin
11/05/2009	US20090274707 Anti-IL-12 Antibodies, Nucleic Acids Encoding Antibodies, and Methods of Production
11/05/2009	US20090274681 Novel gene encoding a dna repair enzyme and methods of use thereof
11/05/2009	US20090274680 Human Phospholipases
11/05/2009	US20090274656 Hepatitis c virus inhibitors
11/05/2009	US20090274622 Necrosis avid tracer agent
11/05/2009	CA2722906A1 Pharmaceutical agent for promoting the functional regeneration of damaged tissue
11/05/2009	CA2722852A1 Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
11/05/2009	CA2722815A1 Use of dronedarone for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level due to dronedarone administration
11/05/2009	CA2722733A1 Cyclopentylacrylamide derivative
11/05/2009	CA2721947A1 Pegylated recombinant human growth hormone compounds
11/05/2009	CA2721560A1 Combination of dronedarone with at least one diuretic, and therapeutic use thereof
11/04/2009	EP2113256A1 PEGylated rhGH compounds
11/04/2009	EP2112926A2 Use of estrogen receptor beta selective ligands for treating acute lung injuries
11/04/2009	EP1928442B1 Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof
11/04/2009	EP1542716B1 Growth hormone releasing peptides
11/04/2009	EP1533304B1 Amide derivative
11/04/2009	EP1532130B1 Process for the production of an immunosuppressant
11/04/2009	EP1499311B1 Substituted benzazoles and use thereof as raf kinase inhibitors
11/04/2009	EP1481077B1 Mitotic kinesin inhibitors
11/04/2009	EP1480736B1 Microcapsules having high carotenoid content
11/04/2009	EP1455773B1 2-aryl-propionic acids and pharmaceutical compositions containing them
11/04/2009	EP1420645B1 Multivesicular emulsion topical delivery systems
11/04/2009	EP1372638B1 Cannabinoids for the treatment of breathing disorders during sleep
11/04/2009	EP1311488B1 Substituted imidazoles as tafia inhibitors
11/04/2009	EP1303488B1 Piperidine compounds for use as ccr-3 inhibitors
11/04/2009	EP1204430B1 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
11/04/2009	CN101570517A 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
11/03/2009	US7612238 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases
11/03/2009	US7612225 Endothelin receptor antagonist, useful for treating various circulatory system diseases such as hypertension, ischemic disorders, cerebral circulatory disorders, renal disorders, circulatory insufficiency of various organs, asthma, stroke
11/03/2009	US7612114 Selective estrogen receptor modulator
11/03/2009	US7612095 Polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1-piperidinyl]ethyl]-αα-dimethyl-benzeneacetic acid
11/03/2009	US7612094 Tri-substituted heteroaryls and methods of making and using the same
11/03/2009	US7612092 Nitrogen-containing aromatic derivatives
11/03/2009	US7612090 Use in treatment of a disorder which is created by or is dependent upon decreased availability of serotonin, norepinephrine or dopamine
11/03/2009	US7612087 Heterocyclic compounds as inhibitors of beta-lactamases
11/03/2009	US7612083 Urea substituted imidazoquinoline ethers
11/03/2009	US7612079 2-(hydroxypiperidin-1-yl or hydroxyisoalkylamino)-6(3-nitrophenylamino, 3,4-dimethoxybenzylamino, pyrid-2-yl-methylamino, pyrid-4-yl-methylamino or indan-5-amino)-9-(isopropyl or cyclopentyl)purines; cell cyclin kinase inhibitors for treating cancer, leukemia, psoriasis and neuronal apoptosis
11/03/2009	US7612077 Crystalline forms of the anti-cancer compound ZD1839
11/03/2009	US7612075 Anticaogulants; cardiovascular disorders
11/03/2009	US7612070 Indole derivative having heterocycle and mono- or diazaindole derivative
11/03/2009	US7612066 1-(3-tert-butyl-4-methoxy-5-morpholinophenyl)-2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)ethanone,; stabilizing the composition; not decompose even when placed under humidification conditions
11/03/2009	US7612059 Pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use
11/03/2009	US7612052 Combinations comprising epothilones and pharmaceutical uses thereof
11/03/2009	US7612050 Via bisphosphonate drug; for prophylaxis of cartilage destruction or chondrolysis associated with osteonecrosis and/or osteochondritis dissecans
11/03/2009	US7612034 Administering calcitonin and dehydroepiandrosterone (DHEA) to patient being treated for systemic lupus erythematosus where the immunosuppressant tends to reduce bone mineral density(BMD); osteoporosis
11/03/2009	US7611832 Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
11/03/2009	US7611734 Use of extracts from Pelargonium species
11/03/2009	US7611716 Method of processing seaweed
11/03/2009	US7611708 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies
11/03/2009	CA2449729C Prodrugs of gaba analogs, compositions and uses thereof
11/03/2009	CA2448035C New pharmaceutical composition
11/03/2009	CA2443724C Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
11/03/2009	CA2418961C Anti-il-12 antibodies, compositions, methods and uses
11/03/2009	CA2415476C Matrix controlled transdermal system for stabile derivatives of ace inhibitors
11/03/2009	CA2410037C 3-phenyl-imidazo-pyrimidine derivatives as ligands for gaba receptors
11/03/2009	CA2407421C Activators of peroxisome proliferator-activated receptors
11/03/2009	CA2385477C Pca3 messenger rna species in benign and malignant prostate tissues
11/03/2009	CA2316356C Benzoxazine compounds for enhancing synaptic response
11/03/2009	CA2174338C Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound
10/2009
10/29/2009	WO2009131435A1 Linker containing bungarotoxin and a binding peptide
10/29/2009	WO2009131256A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof
10/29/2009	WO2009131216A1 Lipid membrane structure modified with oligo(alkylene glycol)
10/29/2009	WO2009131196A1 Substituted pyrrolidine derivative and use thereof
10/29/2009	WO2009131191A1 Metastin derivative and use thereof
10/29/2009	WO2009131173A1 2-aminoquinazoline derivative
10/29/2009	WO2009131171A1 Novel five-membered ring compound
10/29/2009	WO2009131170A1 Five-membered ring compound
10/29/2009	WO2009131164A1 Eye-drop preparation and use thereof
10/29/2009	WO2009131135A1 Iminopyridine derivative and use thereof
10/29/2009	WO2009131129A1 5-hydroxypyrimidine-4-carboxamide compound
10/29/2009	WO2009131127A1 5-hydroxypyrimidine-4-carboxamide compound
10/29/2009	WO2009131098A1 Method of utilization of combination of benzophenone derivative or salt thereof and immunosuppressing agent, and pharmaceutical composition comprising these components
10/29/2009	WO2009131096A1 Compound having npy y5 receptor antagonist activity
10/29/2009	WO2009131090A1 Amino acid compound
10/29/2009	WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009	WO2009129573A1 Nicotinamide derivatives
10/29/2009	US20090271217 Side effect ameliorating combination therapeutic products and systems

1 ... 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 ... 1564